Tick-Borne Diseases in Dogs: Comprehensive Review of Common Pathogens, Clinical Syndromes, and Management

Introduction

Tick-borne diseases represent a significant and growing concern in canine veterinary medicine worldwide. The geographic distribution of tick vectors and their associated pathogens is expanding due to climatic shifts, habitat alteration, and increased animal movement [1]. Domestic dogs are exposed to many ixodid tick species that serve as biological vectors for bacteria, protozoa, and rickettsiae [1]. The clinical syndromes resulting from these infections range from subclinical carrier states to acute, life-threatening multisystemic disease. This review provides a comprehensive examination of the major tick-borne pathogens affecting dogs, their transmission dynamics, clinical presentations, diagnostic approaches, and evidence-based management strategies.

Tick Vectors and Transmission Ecology

The transmission of tick-borne pathogens to dogs is mediated primarily by hard ticks of the family Ixodidae. In temperate regions, Ixodes ricinus and Ixodes scapularis are principal vectors for Borrelia burgdorferi sensu lato and [Anaplasma phagocytophilum](/knowledge/bacteria/Equine Granulocytic Anaplasmosis/anaplasma-phagocytophilum-equine-granulocytic-anaplasmosis-tick) [1]. In tropical and subtropical environments, Rhipicephalus sanguineus sensu lato (the brown dog tick) is the dominant vector for Ehrlichia canis, Anaplasma platys, and Babesia vogeli [1]. Dermacentor variabilis and Dermacentor andersoni transmit Anaplasma marginale and Francisella tularensis in North America, while Amblyomma americanum is associated with Ehrlichia ewingii and Ehrlichia chaffeensis [1].

The biological transmission process involves pathogen acquisition during a blood meal from an infected reservoir host, followed by transstadial passage (from larva to nymph to adult) and subsequent inoculation into a naive canine host during a later feeding event [1]. Transovarial transmission occurs for some pathogens, such as Babesia spp., allowing ticks to serve as both vectors and reservoirs [1]. The duration of tick attachment required for pathogen transmission varies by agent. For Borrelia burgdorferi, transmission typically requires 24 to 48 hours of feeding, whereas Ehrlichia and Anaplasma species can be transmitted within a few hours of attachment [1].

Major Pathogens and Their Clinical Syndromes

Bacterial Pathogens

Borrelia burgdorferi Sensu Lato (Lyme Disease)

Borrelia burgdorferi sensu lato is a spirochete bacterium transmitted by Ixodes spp. ticks. The pathogen establishes infection in the canine host after inoculation into the dermis, where it disseminates hematogenously to target tissues including joints, kidneys, and the heart [2]. The clinical syndrome of canine Lyme disease is characterized by episodic lameness, fever, lymphadenomegaly, and lethargy [2]. A subset of infected dogs develops Lyme nephritis, a severe immune-complex glomerulonephropathy that can progress to renal failure [2]. Cardiac involvement, termed Lyme carditis, is less commonly reported in dogs but has been documented in human medicine as a cause of atrioventricular block and myocardial inflammation [2]. The pathogenesis of Lyme carditis involves immune-mediated injury due to cross-reactivity between Borrelia antigens and cardiac epitopes [2]. In dogs, clinical signs of cardiac involvement may include syncope, exercise intolerance, and arrhythmias [2].

Ehrlichia canis (Canine Monocytic Ehrlichiosis)

Ehrlichia canis is an obligate intracellular gram-negative bacterium that infects monocytes and macrophages. The pathogen is transmitted by Rhipicephalus sanguineus sensu lato [1]. Canine monocytic ehrlichiosis progresses through three clinical phases: acute, subclinical, and chronic. The acute phase, occurring 1 to 3 weeks post-infection, is characterized by fever, depression, anorexia, lymphadenomegaly, splenomegaly, and thrombocytopenia [1]. The subclinical phase may persist for months to years, during which the dog remains seropositive but clinically normal. The chronic phase is marked by severe pancytopenia, bleeding tendencies, epistaxis, petechiation, and secondary infections due to bone marrow suppression [1]. Thrombocytopenia is a hallmark laboratory finding, resulting from immune-mediated destruction and platelet sequestration [1].

[Anaplasma phagocytophilum](/knowledge/bacteria/Equine Granulocytic Anaplasmosis/anaplasma-phagocytophilum-equine-granulocytic-anaplasmosis-tick) (Canine Granulocytic Anaplasmosis)

[Anaplasma phagocytophilum](/knowledge/bacteria/Equine Granulocytic Anaplasmosis/anaplasma-phagocytophilum-equine-granulocytic-anaplasmosis-tick) infects neutrophils and is transmitted by Ixodes spp. ticks [1]. Clinical signs include acute onset fever, lethargy, anorexia, lameness, and polyarthropathy. Thrombocytopenia is common, though less severe than in ehrlichiosis [1]. Neurologic signs, including ataxia and seizures, have been reported in a minority of cases [1].

Anaplasma platys (Canine Cyclic Thrombocytopenia)

Anaplasma platys is a rickettsial pathogen that infects platelets, causing cyclic thrombocytopenia. The pathogen is transmitted by Rhipicephalus sanguineus sensu lato [1]. Clinical signs are often mild and may include fever, lethargy, and petechiation during periods of profound thrombocytopenia. The cyclic nature of the thrombocytopenia, with nadirs occurring every 10 to 14 days, is a diagnostic feature [1].

Protozoal Pathogens

Babesia canis and Babesia gibsoni (Canine Babesiosis)

Babesia spp. are intraerythrocytic protozoan parasites transmitted by ixodid ticks. Babesia canis (large form) is transmitted by Dermacentor reticulatus and Rhipicephalus sanguineus sensu lato, while Babesia gibsoni (small form) is transmitted by Rhipicephalus sanguineus sensu lato and also through dog-to-dog transmission via bite wounds [1]. Clinical babesiosis ranges from subclinical infection to severe hemolytic anemia. Acute disease is characterized by fever, hemoglobinuria, icterus, splenomegaly, and regenerative anemia [1]. Severe cases may progress to disseminated intravascular coagulation, acute kidney injury, and cerebral babesiosis [1].

Rickettsial Pathogens

Rickettsia rickettsii (Rocky Mountain Spotted Fever)

Rickettsia rickettsii is an obligate intracellular bacterium transmitted by Dermacentor spp. ticks. The pathogen infects vascular endothelial cells, leading to widespread vasculitis [1]. Clinical signs include fever, depression, petechiation, edema of the extremities and face, and neurologic signs such as ataxia and seizures. Thrombocytopenia is common, and mortality can be high without prompt treatment [1].

Diagnostic Approaches

Diagnosis of tick-borne diseases in dogs relies on a combination of clinical assessment, hematologic and biochemical profiling, serologic testing, and molecular detection methods.

Hematologic and Biochemical Findings

Complete blood count and serum biochemistry provide supportive evidence for tick-borne disease. Thrombocytopenia is a consistent finding in ehrlichiosis, anaplasmosis, and Rocky Mountain spotted fever [1]. Anemia, either regenerative (babesiosis) or non-regenerative (chronic ehrlichiosis), is frequently observed. Pancytopenia in chronic E. canis infection indicates bone marrow suppression [1]. Serum biochemistry may reveal hyperglobulinemia, particularly in chronic ehrlichiosis, and azotemia in cases of Lyme nephritis or babesiosis-associated kidney injury [1].

Serologic Testing

Serologic assays detect antibodies against tick-borne pathogens. Indirect immunofluorescence assays and enzyme-linked immunosorbent assays (ELISAs) are commonly used. For Borrelia burgdorferi, detection of antibodies against the C6 peptide is specific for active infection [2]. Seroconversion typically occurs 2 to 4 weeks post-infection, so acute and convalescent titers may be necessary for diagnosis [1]. Cross-reactivity between Ehrlichia and Anaplasma species can occur, necessitating confirmatory molecular testing [1].

Molecular Detection

Polymerase chain reaction (PCR) assays offer high sensitivity and specificity for direct detection of pathogen DNA in blood, tissue, or tick samples. Real-time PCR allows quantification of pathogen load and is particularly useful for monitoring treatment response [1]. PCR is the method of choice for detecting Babesia spp. in the acute phase of infection, when parasitemia is highest [1]. For Ehrlichia and Anaplasma species, PCR can detect infection before seroconversion [1].

Microscopic Examination

Examination of Giemsa-stained blood smears can reveal intraerythrocytic Babesia organisms (pear-shaped merozoites) or intracytoplasmic morulae in monocytes (E. canis) or neutrophils (A. phagocytophilum) [1]. However, sensitivity is low, and negative smears do not rule out infection [1].

Management and Treatment

Antimicrobial Therapy

Doxycycline is the first-line antimicrobial for treatment of Ehrlichia canis, Anaplasma phagocytophilum, Anaplasma platys, and Rickettsia rickettsii [1]. The recommended dosage is 10 mg/kg orally every 24 hours for 28 days for ehrlichiosis and 14 days for anaplasmosis [1]. For Borrelia burgdorferi infection, doxycycline at 10 mg/kg every 24 hours for 30 days is standard [2]. In cases of Lyme carditis, prompt initiation of antibiotic therapy is essential to reduce the duration of disease and minimize complications [2].

For canine babesiosis, imidocarb dipropionate at 5 to 6.6 mg/kg intramuscularly or subcutaneously, repeated once after 14 days, is effective against Babesia canis [1]. Atovaquone combined with azithromycin is used for Babesia gibsoni infections, which are often resistant to imidocarb [1].

Supportive Care

Supportive therapy is critical in severe cases. Intravenous fluid therapy is indicated for dehydrated or azotemic patients. Blood transfusions may be necessary in cases of severe anemia from babesiosis or pancytopenia from chronic ehrlichiosis [1]. Corticosteroids are sometimes used to manage immune-mediated complications, such as immune-mediated hemolytic anemia secondary to babesiosis or immune-mediated thrombocytopenia in ehrlichiosis, but their use must be carefully weighed against the risk of immunosuppression [1].

Prognosis

The prognosis for most tick-borne diseases is good with early diagnosis and appropriate therapy. Chronic E. canis infection carries a guarded prognosis due to the potential for irreversible bone marrow damage [1]. Lyme nephritis has a poor prognosis, with many dogs progressing to end-stage renal disease despite aggressive therapy [2].

Prevention

Prevention of tick-borne diseases centers on effective tick control. Acaricidal products, including isoxazoline-class drugs (e.g., afoxolaner, fluralaner, sarolaner), provide rapid and sustained killing of ticks [1]. Monthly topical or oral administration is recommended in endemic areas. Additionally, minimizing tick habitat exposure and performing daily tick checks after outdoor activity reduce the risk of attachment and transmission [1].

Vaccination against Borrelia burgdorferi is available and recommended for dogs in endemic regions. Vaccination reduces the risk of infection and clinical disease but does not prevent tick attachment [2]. No vaccines are currently available for Ehrlichia, Anaplasma, Babesia, or Rickettsia species [1].

Diagnostic and Management Decision Framework

The following Mermaid diagram outlines a clinical decision pathway for the diagnosis and management of suspected tick-borne disease in dogs.

flowchart TD
 A[Canine patient with fever, lethargy, lameness, or bleeding] --> B{History of tick exposure?}
 B -->|Yes| C[Perform CBC, serum biochemistry, blood smear]
 B -->|No| D[Consider other differentials]
 C --> E{Thrombocytopenia present?}
 E -->|Yes| F[Serologic testing for Ehrlichia, Anaplasma, Borrelia, Rickettsia]
 E -->|No| G[PCR for Babesia, Ehrlichia, Anaplasma]
 F --> H{Positive serology?}
 H -->|Yes| I[Confirm with PCR if available]
 H -->|No| J[Repeat serology in 2-4 weeks]
 I --> K[Initiate doxycycline therapy]
 G --> L{Positive PCR?}
 L -->|Yes| M[Targeted therapy based on pathogen]
 L -->|No| N["Monitor clinically; consider other etiologies"]
 K --> O[Re-evaluate in 48-72 hours]
 O --> P{Clinical improvement?}
 P -->|Yes| Q[Complete full course of antibiotics]
 P -->|No| R["Reassess diagnosis; consider co-infections or complications"]

Conclusion

Tick-borne diseases in dogs encompass a diverse group of bacterial, protozoal, and rickettsial pathogens transmitted by ixodid ticks. The clinical syndromes range from acute febrile illness to chronic debilitating disease. Accurate diagnosis requires integration of clinical signs, hematologic findings, serology, and molecular testing. Early treatment with appropriate antimicrobials, particularly doxycycline for most bacterial and rickettsial agents, is associated with favorable outcomes. Prevention through rigorous tick control and, where available, vaccination remains the cornerstone of managing these infections. Ongoing surveillance of tick vector populations and pathogen prevalence is essential for understanding emerging risks and informing veterinary practice [1].

References

[1] Kocoń A, Nowak-Chmura M, Asman M, et al. Review of ticks attacking domestic dogs and cats, and their epidemiological role in the transmission of tick-borne pathogens in Poland. Ann Agric Environ Med. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/36999852/

[2] Radesich C, Del Mestre E, Medo K, et al. Lyme Carditis: From Pathophysiology to Clinical Management. Pathogens. 2022. URL: https://www.semanticscholar.org/paper/69ad35652f420a2ffcf18a472561b41401eb9ebd *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.